Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

411
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
411
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

589
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
589
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

890
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
890
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

417
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
417
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

820
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
820
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

712
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
712

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Factors for Small Bowel Crohn's Disease Recurrence after Total Proctocolectomy.

Diseases of the colon and rectum·2026
Same author

GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Same author

Clinical Practice Guideline for the Surgical Management of Ulcerative Colitis.

Diseases of the colon and rectum·2026
Same author

Rethinking Intestinal Stem Cells: Why Fgfbp1 + Progenitors Might Be More Critical Than the Lgr5 + Population.

Diseases of the colon and rectum·2026
Same author

Use of barbed suture in surgery and the risk of intestinal obstruction: analysis of a large institutional cohort.

Surgical endoscopy·2026
Same author

Flap-Assisted Perineal Closure After Proctectomy for Crohn's Disease.

Diseases of the colon and rectum·2025

Related Experiment Video

Updated: Jan 4, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

17.1K

Preoperative Considerations in Inflammatory Bowel Disease.

Nicholas P McKenna1, Amy L Lightner2

  • 1Department of Surgery, Mayo Clinic, 200 1st Street Southwest, Rochester, MN 55905, USA.

The Surgical Clinics of North America
|November 3, 2019
PubMed
Summary

For patients with inflammatory bowel disease undergoing surgery, malnutrition and immunosuppression impact outcomes. Temporary intestinal diversion and nutritional optimization are recommended to improve surgical results.

Keywords:
BiologicsCorticosteroidsCrohn's diseaseEnteral nutritionPreoperative medicationsUlcerative colitis

More Related Videos

Author Spotlight: Isolation and Characterization of Equine Submucosal Enteric Glia — Implications for Preventing Postoperative Complications in Colic Surgery
08:07

Author Spotlight: Isolation and Characterization of Equine Submucosal Enteric Glia — Implications for Preventing Postoperative Complications in Colic Surgery

Published on: October 4, 2024

715
Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
06:11

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique

Published on: May 2, 2025

466

Related Experiment Videos

Last Updated: Jan 4, 2026

Murine Ileocolic Bowel Resection with Primary Anastomosis
08:49

Murine Ileocolic Bowel Resection with Primary Anastomosis

Published on: October 29, 2014

17.1K
Author Spotlight: Isolation and Characterization of Equine Submucosal Enteric Glia — Implications for Preventing Postoperative Complications in Colic Surgery
08:07

Author Spotlight: Isolation and Characterization of Equine Submucosal Enteric Glia — Implications for Preventing Postoperative Complications in Colic Surgery

Published on: October 4, 2024

715
Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
06:11

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique

Published on: May 2, 2025

466

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Immunology

Background:

  • Patients with ulcerative colitis and Crohn's disease frequently have malnutrition and are on combined immunosuppressive therapy before surgery.
  • These conditions significantly influence surgical decisions and postoperative recovery.
  • Corticosteroids are known to negatively affect surgical outcomes, while the effects of biologic agents remain less clear.

Purpose of the Study:

  • To analyze the impact of malnutrition and immunosuppression on surgical outcomes in inflammatory bowel disease (IBD) patients.
  • To guide the selection of surgical procedures and perioperative management strategies for IBD patients.
  • To evaluate the role of temporary intestinal diversion and nutritional support in optimizing surgical outcomes.

Main Methods:

  • Review of existing literature on surgical outcomes in IBD patients treated with immunosuppressants.
  • Analysis of the effects of corticosteroids and biologic agents on postoperative complications.
  • Assessment of the benefits of enteral nutrition and temporary intestinal diversion.

Main Results:

  • Malnutrition and combination immunosuppression are critical factors affecting surgical choices and outcomes in IBD.
  • Corticosteroids demonstrate a clear negative impact on postoperative results.
  • The influence of biologic agents on surgical outcomes requires further investigation, but temporary diversion is often preferred in high-risk patients.

Conclusions:

  • Temporary intestinal diversion is a preferred surgical approach for IBD patients with risk factors, including immunosuppression.
  • Enteral nutrition can be a valuable tool for optimizing the nutritional status of high-risk patients, potentially mitigating adverse postoperative outcomes.
  • Careful consideration of patient's nutritional status and medication regimen is essential for successful surgical management of IBD.